ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Tris Pharma? Acquires Park Therapeutics americanpharmaceuticalreview
April 30, 2021Tris Pharma, Inc., a specialty pharmaceutical company with a portfolio of approved products and a late-stage pipeline of product candidates for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related conditions, has acquired Park ... -
Tris Pharma, Athena Bioscience Enter Exclusive License Agreement contractpharma
February 23, 2021Athena gains exclusive rights to commercialize a long-acting antihypertensive product developed using Tris' proprietary technology.
Pharma Sources Insight January 2025
